Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026)
Emergent BioSolutions (EBS) reported Treasury Shares of $270.5 million for Q2 2026, up 15.3% from $234.6 million a year earlier and up 3.4% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Treasury Shares (2012 - 2026) Analysis & Trends
At the end of FY2025, Emergent BioSolutions posted Treasury Shares of $252.6 million, up 10.9% from FY2024.
- Treasury Shares has a five-year compound annual growth rate of 44.9% (FY2020 to FY2025).
- By year, Treasury Shares came in at $227.7 million in FY2024 (unchanged), $227.7 million in FY2023 (unchanged), $227.7 million in FY2022 (+49.6%) and $152.2 million in FY2021 (+284.3%).
- The Q2 2026 figure ranks as the highest quarterly Treasury Shares in data going back to Q3 2012.
- Year over year, Treasury Shares has now increased in each of the last five quarters, with growth averaging 6.4% over the last eight quarters.
- Over the past five years, the year-over-year growth in Treasury Shares ranged from 0.0% (Q3 2021) to 475.0% (Q3 2022).
- Per Business Quant data, the three quarters before Q2 2026 came in at $261.6 million (Q1 2026), $252.6 million (Q4 2025) and $243.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,147.42 Bn | 1,116.01 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.36 Bn | 541.89 Bn | 17.26 Bn | 711.62 Mn |
| 3 | AbbVie | 509.56 Bn | 482.67 Bn | 12.70 Bn | 77.11 Mn |
| 4 | Merck | 365.93 Bn | 320.31 Bn | 12.21 Bn | 1.11 Bn |
| 5 | Novartis Ag | 297.31 Bn | 261.30 Bn | 11.24 Bn | 49.00 Mn |
| 6 | Astrazeneca | 261.52 Bn | 235.20 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.01 Bn | 190.41 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 193.77 Bn | 167.97 Bn | 6.22 Bn | - |
| 9 | Pfizer | 171.91 Bn | 118.56 Bn | 10.94 Bn | 3.94 Bn |
| 10 | Emergent BioSolutions | 323.02 Mn | -427.88 Mn | 137.20 Mn | 10.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.70 Mn |
| Mar 31, 2026 | 9.60 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 7.90 Mn |
| Jun 30, 2025 | 6.70 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Dec 31, 2024 | 5.60 Mn |
| Sep 30, 2024 | 5.60 Mn |
| Jun 30, 2024 | 5.60 Mn |
| Mar 31, 2024 | 5.60 Mn |
| Dec 31, 2023 | 5.60 Mn |
| Sep 30, 2023 | 5.60 Mn |
| Jun 30, 2023 | 5.60 Mn |
| Mar 31, 2023 | 5.60 Mn |
| Dec 31, 2022 | 5.60 Mn |
| Sep 30, 2022 | 5.60 Mn |
| Jun 30, 2022 | 5.60 Mn |
| Mar 31, 2022 | 4.90 Mn |
| Dec 31, 2021 | 3.80 Mn |
| Sep 30, 2021 | 1.20 Mn |
API Access
Emergent BioSolutions Treasury Shares API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=treasury-shares&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "treasury-shares", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=treasury-shares&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();